Journavx Market Access Strategy in Focus: What ...

By Rene Pretorius

March 17, 2025

Vertex Pharmaceuticals’ Journavx, a non-opioid pain medication, received
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
Global Childhood Cancer Access
New Global AIDS Strategy 2030 Aims to End AIDS Threat by 2030
Lenacapavir HIV Prevention: Approval and Access Strategy Updates
Genetic Testing in South Africa
PEPFAR Funding Pause Threatens Global HIV Progress
Healthcare at Home: CMC Dubai’s Innovative Program
Cost-Effective CML Treatment in South Africa
Trends in Endometrial Cancer Mortality
Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in Kwa...
Medicare Drug Negotiations Target Ozempic and Ibrance for Price Cuts
Thyroid Cancer Diagnosis: Delays During the Pandemic, Implications and Trends